Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Hot Products

Rokote Laboratories selects Exothera for GMP manufacturing of its second-generation coronavirus vaccine FINCoVac 2.0.

PharmaSources.comApril 07, 2022

Tag: Rokote Laboratories , Exothera , GMP manufacturing , coronavirus vaccine , FINCoVac 2.0.